Responses
Regular Abstracts – Part 2
Immune-Stimulants and Immune Modulators
1147-H Novel immunotherapy regiment approach for pancreatic ductal adenocarcinoma (PDCA) using human MUC1 transgenic mice (MUC1.tg) model: optimizing conditions for MVA vaccine evaluation
Compose a Response to This Article
Other responses
No responses have been published for this article.
